Cargando…
Measuring informed consent capacity in an Alzheimer's disease clinical trial
INTRODUCTION: Accurately and efficiently determining a participant's capacity to consent to research is critically important to protect the rights of patients with Alzheimer's disease (AD). METHODS: Understanding of the informed consent document was assessed in 613 community-dwelling patie...
Autores principales: | Guarino, Peter D., Vertrees, Julia E., Asthana, Sanjay, Sano, Mary, Llorente, Maria D., Pallaki, Muralidhar, Love, Susan, Schellenberg, Gerard D., Dysken, Maurice W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651363/ https://www.ncbi.nlm.nih.gov/pubmed/29067313 http://dx.doi.org/10.1016/j.trci.2016.09.001 |
Ejemplares similares
-
Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease
por: Belitskaya-Lévy, Ilana, et al.
Publicado: (2018) -
Adults with capacity - a practical guide to gaining consent
por: Crawley, Katie
Publicado: (2022) -
The Potential Perils of Informed Consent
por: Loftus, Elizabeth F., et al.
Publicado: (2008) -
The ethics of consent during labour and birth: episiotomies
por: van der Pijl, Marit, et al.
Publicado: (2023) -
Association of mitochondrial variants and haplogroups identified by whole exome sequencing with Alzheimer's disease
por: Zhang, Xiaoling, et al.
Publicado: (2021)